Palexia retard 200 mg Retardtabletten
Country: Germany
Language: German
Source: BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Tapentadolhydrochlorid
Available from:
HAEMATO PHARM GmbH (8090132)
Dosage:
200 mg
Pharmaceutical form:
Retardtablette
Composition:
Teil 1 - Retardtablette; Tapentadolhydrochlorid (32875) 232,96 Milligramm
Administration route:
zum Einnehmen
Authorization status:
zugelassen
Authorization date:
2021-06-22
